Candel Therapeutics (CADL) Net Margin Growth (1y) (2021 - 2022)

Candel Therapeutics (CADL) Net Margin Growth (1y) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -763.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 447.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 673.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,097.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,208.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,636.00
10 Candel Therapeutics 643.41 Mn 643.41 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 40.58 Mn
Sep 30, 2022 -373,871.00
Jun 30, 2022 -1.23 Mn
Mar 31, 2022 -10.80 Mn
Dec 31, 2021 -37.86 Mn
Sep 30, 2021 -1.66 Mn
Jun 30, 2021 -969,032.00